These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25967993)

  • 1. Biomarkers of necrotising soft tissue infections: aspects of the innate immune response and effects of hyperbaric oxygenation-the protocol of the prospective cohort BIONEC study.
    Hansen MB; Simonsen U; Garred P; Hyldegaard O
    BMJ Open; 2015 May; 5(5):e006995. PubMed ID: 25967993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of Necrotising Soft Tissue Infections Aspects of the Innate Immune Response.
    Hansen MB
    Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How biomarkers reflect the prognosis and treatment of necrotising soft tissue infections and the effects of hyperbaric oxygen therapy: the protocol of the prospective cohort PROTREAT study conducted at a tertiary hospital in Copenhagen, Denmark.
    Polzik P; Johansson PI; Hyldegaard O
    BMJ Open; 2017 Oct; 7(10):e017805. PubMed ID: 28982834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentraxin-3 as a marker of disease severity and risk of death in patients with necrotizing soft tissue infections: a nationwide, prospective, observational study.
    Hansen MB; Rasmussen LS; Garred P; Bidstrup D; Madsen MB; Hyldegaard O
    Crit Care; 2016 Feb; 20():40. PubMed ID: 26880104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Not just full of hot air: hyperbaric oxygen therapy increases survival in cases of necrotizing soft tissue infections.
    Shaw JJ; Psoinos C; Emhoff TA; Shah SA; Santry HP
    Surg Infect (Larchmt); 2014 Jun; 15(3):328-35. PubMed ID: 24786980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between cytokine response, the LRINEC score and outcome in patients with necrotising soft tissue infection: a multicentre, prospective study.
    Hansen MB; Rasmussen LS; Svensson M; Chakrakodi B; Bruun T; Madsen MB; Perner A; Garred P; Hyldegaard O; Norrby-Teglund A;
    Sci Rep; 2017 Feb; 7():42179. PubMed ID: 28176831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of necrotising infection clinical composite endpoint in a retrospective cohort of patients with necrotising soft tissue infections.
    Bion V; Jape D; Niesen R; Angliss M; Bruscino-Raiola F; Mitra B; Devaney B
    Diving Hyperb Med; 2024 Sep; 54(3):155-161. PubMed ID: 39288918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement Activation Is Associated With Mortality in Patients With Necrotizing Soft-Tissue Infections-A Prospective Observational Study.
    Kristensen MK; Hansen MB; Madsen MB; Hansen CB; Pilely K; Hyldegaard O; Garred P
    Front Immunol; 2020; 11():17. PubMed ID: 32082310
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hyperbaric oxygen therapy for necrotizing soft tissue infections: contra].
    Willy C; Rieger H; Vogt D
    Chirurg; 2012 Nov; 83(11):960-72. PubMed ID: 23138865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in necrotizing soft-tissue infections (NSTI): A cohort study.
    Hua C; Sbidian E; Hemery F; Decousser JW; Bosc R; Amathieu R; Rahmouni A; Wolkenstein P; Valeyrie-Allanore L; Brun-Buisson C; de Prost N; Chosidow O
    J Am Acad Dermatol; 2015 Dec; 73(6):1006-12.e8. PubMed ID: 26412163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary national outcomes of hyperbaric oxygen therapy in necrotizing soft tissue infections.
    Toppen W; Cho NY; Sareh S; Kjellberg A; Medak A; Benharash P; Lindholm P
    PLoS One; 2024; 19(3):e0300738. PubMed ID: 38512943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scarce evidence of efficacy of hyperbaric oxygen therapy in necrotizing soft tissue infection: a systematic review.
    Faunø Thrane J; Ovesen T
    Infect Dis (Lond); 2019 Jul; 51(7):485-492. PubMed ID: 30985236
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors associated with mortality in patients with extremity necrotizing soft-tissue infections: a single academic center experience.
    Nagira K; Ogoshi T; Akahori K; Enokida S; Enokida M; Ueda T; Homma M; Nagashima H
    Langenbecks Arch Surg; 2023 May; 408(1):189. PubMed ID: 37166568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reported outcome measures in necrotising soft tissue infections: a systematic review.
    Wackett J; Devaney B; Chau R; Ho J; King N; Grewal J; Armstrong J; Mitra B
    Diving Hyperb Med; 2024 Mar; 54(1):47-56. PubMed ID: 38507909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive hyperbaric oxygen treatment for necrotising soft-tissue infections: A systematic review and meta-analysis.
    Hedetoft M; Bennett MH; Hyldegaard O
    Diving Hyperb Med; 2021 Mar; 51(1):34-43. PubMed ID: 33761539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are we getting necrotizing soft tissue infections right? A 10-year review.
    Proud D; Bruscino Raiola F; Holden D; Paul E; Capstick R; Khoo A
    ANZ J Surg; 2014 Jun; 84(6):468-72. PubMed ID: 24164901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocompromised status in patients with necrotizing soft-tissue infection.
    Keung EZ; Liu X; Nuzhad A; Adams C; Ashley SW; Askari R
    JAMA Surg; 2013 May; 148(5):419-26. PubMed ID: 23677405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperbaric oxygen treatment is associated with a decrease in cytokine levels in patients with necrotizing soft-tissue infection.
    Hedetoft M; Garred P; Madsen MB; Hyldegaard O
    Physiol Rep; 2021 Mar; 9(6):e14757. PubMed ID: 33719215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No role for standard imaging workup of patients with clinically evident necrotizing soft tissue infections: a national retrospective multicenter cohort study.
    Brands SR; Nawijn F; Foppen W; Hietbrink F
    Eur J Trauma Emerg Surg; 2024 Jun; 50(3):875-885. PubMed ID: 38253724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equipoise: an important ethical consideration when contemplating participation in a randomised controlled trial of hyperbaric oxygen treatment in necrotising soft tissue infections.
    Devaney B
    Diving Hyperb Med; 2024 Mar; 54(1):57-60. PubMed ID: 38507910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.